Adaptive Biotechnologies CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Adaptive Biotechnologies Corporation announces its 2026 Annual Meeting of Shareholders to be held virtually on June 5, 2026.
NASDAQ
DEFA14A: Adaptive Biotechnologies Sets Date for Annual Shareholder Meeting, Seeks Approval on Key Proposals
Adaptive Biotechnologies will hold its annual shareholder meeting on June 10, 2025, seeking votes on director election, executive compensation, and auditor ratification.
NASDAQ
DEF: Adaptive Biotechnologies Corporation Announces 2025 Annual Meeting and Highlights 2024 Performance
Adaptive Biotechnologies Corporation invites shareholders to its 2025 Annual Meeting and reports on 2024 corporate performance, including revenue growth in the MRD business and reduced operating expenses.
NASDAQ
Adaptive Biotechnologies urges stockholders to re-elect directors Peter Neupert and Michelle Griffin, addressing concerns raised by ISS regarding Dr. Rob Hershberg's board memberships.
NASDAQ
Adaptive Biotechnologies Corporation will hold its annual shareholder meeting on June 7, 2024, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
Adaptive Biotechnologies Corporation will hold its 2024 Annual Meeting of Shareholders virtually on June 7, 2024, to vote on director elections, executive compensation, and auditor ratification.